Cited by 458Treatment of Major DepressionAntioxidant Activity and Oxidative StressTryptophan and brain disorders

The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.

Oxidative damage and major depression: the potential antioxidant action of selective serotonin re-uptake inhibitors

Open access

Khanzode, Suchet D., Dakhale, Ganesh N., Khanzode, Shruti S., Saoji, Anand, Palasodkar, R.·2003·Redox Report

Open this paper in CoChat — free account Open PDF

Abstract

There is evidence of derangement of oxidant and antioxidant defense systems in depression. The present study examined the effects of fluoxetine and citalopram, standard selective serotonin re-uptake inhibitors, on lipid peroxidation, superoxide dismutase (SOD) activity and ascorbic acid concentrations. For this, a prospective open-labeled, randomized design was utilized. Patients with major depression (n = 62) were compared with age- and sex-matched healthy volunteers (n = 40). There was a significant increase in serum SOD, serum MDA and decrease in plasma ascorbic acid levels in patients of major depression as compared to control subjects. The trend reversed significantly after treatment with fluoxetine and citalopram. Results indicate a greater reduction in oxidative stress with citalopram than fluoxetine. The Hamilton Rating Scale for Depression (HRSD) score also improved with fluoxetine and citalopram treatment. These findings indicate that major depression is associated with increased levels of serum SOD, serum MDA and decreased levels of plasma ascorbic acid. Treatment with fluoxetine and citalopram reversed these biochemical parameters. This study can be used as a predictor of drug response by fluoxetine and citalopram in major depression.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1179/135100003225003393

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

A rating scale for depression
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817
Oxygen toxicity, oxygen radicals, transition metals and disease
Halliwell, B., & Gutteridge, J. M. C. (1984) · Biochemical Journal · doi:10.1042/bj2190001 · Cited by 5,330
Superoxide radical and superoxide dismutases
Fridovich, I. (1995) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.64.070195.000525 · Cited by 3,455
Serum lipid peroxide in cerebrovascular disorders determined by a new colorimetric method
Kei, S. (1978) · Clinica Chimica Acta · doi:10.1016/0009-8981(78)90081-5 · Cited by 1,730
Serum lipid peroxide in cerebrovascular disorders determined by a new colorimetric method
佐藤, 敬. (1979) · Medical Entomology and Zoology · Cited by 1,520
Superoxide Radical: An Endogenous Toxicant
Fridovich, I. (1983) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.23.040183.001323 · Cited by 1,168
Antioxidative enzyme activities and lipid peroxidation in major depression: alterations by antidepressant treatments
Bilici, M., Efe, H., Köroğlu, M. A., Uydu, H. A., Bekaroğlu, M., & Değer, O. (2001) · Journal of Affective Disorders · doi:10.1016/s0165-0327(00)00199-3 · Cited by 718
Dietary polyunsaturated fatty acids and depression: when cholesterol does not satisfy
Hibbeln, J. R., & Salem, N. (1995) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/62.1.1 · Cited by 525
Lowered ω3 polyunsaturated fatty acids in serum phospholipids and cholesteryl esters of depressed patients
Maes, M. H. J., Christophe, A. B., Delanghe, J., Altamura, C. A., Neels, H. M., & Meltzer, H. Y. (1999) · Psychiatry Research · doi:10.1016/s0165-1781(99)00014-1 · Cited by 452
Manganese superoxide dismutase (MnSOD) genetic polymorphisms, dietary antioxidants, and risk of breast cancer.
Ambrosone, C. B., Freudenheim, J. L., Thompson, P. A., Bowman, E. D., Vena, J. E., Marshall, J. R., Graham, S., Laughlin, R., Nemoto, T., & Shields, P. G. (1999) · PubMed · Cited by 400

Show all 27 references

Research works printed but not linked: 12

Ravikumar A, 2000, Indian J Exp Biol, 38, 438
Bilici M, 2001, J Affect Disord, 88, 69
Cohen G, 1984, Neurotoxicology, 5, 77
Stocks J, 1974, Clin Sci Mol Med, 47, 215
Baldessarini RJ. Drugs and the treatment of psychiatric disorders: depression and mania. In: Molinoff PB, Ruddon RW. (eds) Goodman and Gilman 's - The Pharmacological Basis of Therapeutics. 10th edn. New York: McGraw-Hill, 2000; 447-480.
Nischal HK, 1998, J Assoc Physicians India, 46, 853
Shigennobu UMS, 1987, Clin Chem, 31, 2230
Ambrosone CB, 1999, Cancer Res, 59, 602
Sen CK, 1995, Indian J Physiol Pharmacol, 39, 177
Sen CK, 1994, Physiological antioxidants, 89
Li XM, 2000, J Psychiatr Neurosci, 25, 43
Bezchlibnyk K, 2000, J Psychiatr Neurosci, 25, 241

Sorted by citations

Items 101–200 of 455

Are Anxiety Disorders Associated with Accelerated Aging? A Focus on Neuroprogression
Perna, G., Iannone, G., Alciati, A., & Caldirola, D. (2015) · Neural Plasticity · doi:10.1155/2016/8457612 · Cited by 100
A Review of Biomarkers in Mood and Psychotic Disorders: A Dissection of Clinical vs. Preclinical Correlates
Brand, S., Moller, M., & Harvey, B. (2015) · Current Neuropharmacology · doi:10.2174/1570159x13666150307004545 · Cited by 95
Neuroimmunomodulation in Major Depressive Disorder: Focus on Caspase 1, Inducible Nitric Oxide Synthase, and Interferon-Gamma
Inserra, A., Mastronardi, C. A., Rogers, G. B., Licinio, J., & Wong, M. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1359-3 · Cited by 99
Elevated serum levels of malondialdehyde and cortisol are associated with major depressive disorder: A case-control study
Islam, M. R., Islam, M. R., Ahmed, I., Moktadir, A. A., Nahar, Z., Islam, M. S., Shahid, S. F. B., Islam, S. N., Islam, S., & Hasnat, A. (2018) · SAGE Open Medicine · doi:10.1177/2050312118773953 · Cited by 94
Folic acid prevents depressive-like behavior and hippocampal antioxidant imbalance induced by restraint stress in mice
Budni, J., Zomkowski, A. D. E., Engel, D. F., Santos, D. B., dos Santos, A. A., Moretti, M., Valvassori, S. S., Ornell, F. R., Quevedo, J., Farina, M., et al. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2012.10.024 · Cited by 94
Pre- and post-treatments with escitalopram protect against experimental ischemic neuronal damage via regulation of BDNF expression and oxidative stress
Lee, C. H., Park, J. H., Yoo, K., Choi, J. H., Hwang, I. K., Ryu, P. D., Kim, D., Kwon, Y., Kim, Y., & Won, M. (2011) · Experimental Neurology · doi:10.1016/j.expneurol.2011.03.015 · Cited by 93
Role of Immune-Inflammatory and Oxidative and Nitrosative Stress Pathways in the Etiology of Depression: Therapeutic Implications
Anderson, G., Berk, M., Dean, O. M., Moylan, S., & Maes, M. H. J. (2013) · CNS Drugs · doi:10.1007/s40263-013-0119-1 · Cited by 95
An intriguing and hitherto unexplained co-occurrence: Depression and chronic fatigue syndrome are manifestations of shared inflammatory, oxidative and nitrosative (IO&NS) pathways
Maes, M. H. J. (2010) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.06.023 · Cited by 98
Antidepressant-like effect of quercetin in bulbectomized mice and involvement of the antioxidant defenses, and the glutamatergic and oxidonitrergic pathways
Holzmann, I., da Silva, L. M., da Silva, J. A. C., Steimbach, V. M. B., & de Souza, M. M. (2015) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2015.07.003 · Cited by 92
Protective Effects of Ascorbic Acid on Behavior and Oxidative Status of Restraint-Stressed Mice
Moretti, M., Budni, J., Santos, D. B., Antunes, A. A., Daufenbach, J. F., Manosso, L. M., Farina, M., & Rodrigues, A. L. S. (2012) · Journal of Molecular Neuroscience · doi:10.1007/s12031-012-9892-4 · Cited by 92
Resveratrol exerts antidepressant properties in the chronic unpredictable mild stress model through the regulation of oxidative stress and mTOR pathway in the rat hippocampus and prefrontal cortex
Liu, S., Li, T., Liu, H., Wang, X., Bo, S., Xie, Y., Bai, X., Wu, L., Wang, Z., & Liu, D. (2016) · Behavioural Brain Research · doi:10.1016/j.bbr.2016.01.037 · Cited by 89
Increased autoimmune responses against auto-epitopes modified by oxidative and nitrosative damage in depression: Implications for the pathways to chronic depression and neuroprogression
Maes, M. H. J., Kubera, M., Mihaylova, I., Geffard, M., Gałecki, P., Leunis, J.-C., & Berk, M. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.06.039 · Cited by 87
Venlafaxine protects against stress-induced oxidative DNA damage in hippocampus during antidepressant testing in mice
Abdel-Wahab, B. A., & Salama, R. H. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.07.015 · Cited by 86
Evaluation of malondialdehyde, superoxide dismutase and catalase activity and their diagnostic value in drug naïve, first episode, non-smoker major depression patients and healthy controls
Camkurt, M. A., Fındıklı, E., İzci, F., Kurutaş, E. B., & Tuman, T. C. (2016) · Psychiatry Research · doi:10.1016/j.psychres.2016.01.075 · Cited by 86
Association Between Type D Personality, Depression, and Oxidative Stress in Patients With Chronic Heart Failure
Kupper, N., Gidron, Y., Winter, J., & Denollet, J. (2009) · Psychosomatic Medicine · doi:10.1097/psy.0b013e3181bee6dc · Cited by 85
Schizophrenia is primed for an increased expression of depression through activation of immuno-inflammatory, oxidative and nitrosative stress, and tryptophan catabolite pathways
Anderson, G., Maes, M. H. J., & Berk, M. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.07.016 · Cited by 86
How Oxidative Stress Induces Depression?
Ji, N., Lei, M., Chen, Y., Tian, S., Li, C., & Zhang, B. (2023) · ASN NEURO · doi:10.1177/17590914231181037 · Cited by 84
Mitochondria and the central nervous system: searching for a pathophysiological basis of psychiatric disorders
STRECK, E. L., Gonçalves, C. L., Furlanetto, C. B., Scaini, G., Dal‐Pizzol, F., & Quevedo, J. (2014) · Brazilian Journal of Psychiatry · doi:10.1590/1516-4446-2013-1224 · Cited by 85
Behavioral and biochemical studies of total furocoumarins from seeds of Psoralea corylifolia in the forced swimming test in mice
Chen, Y., Kong, L., Xia, X. H., Kung, H., & Zhang, L. (2004) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2004.09.033 · Cited by 81
Antidepressant-like effect of ascorbic acid is associated with the modulation of mammalian target of rapamycin pathway
Moretti, M., Budni, J., Freitas, A. E., da Rosa, P. B., & Rodrigues, A. L. S. (2013) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2013.10.014 · Cited by 82
Increased activities of both superoxide dismutase and catalase were indicators of acute depressive episodes in patients with major depressive disorder
Tsai, M.-C., & Huang, T. (2015) · Psychiatry Research · doi:10.1016/j.psychres.2015.12.005 · Cited by 81
Nutrition and depressive symptoms in community-dwelling elderly persons in Japan.
Oishi, J., Doi, H., & Kawakami, N. (2009) · PubMed · doi:10.18926/amo/31854 · Cited by 80
The antidepressant-like effects of Origanum majorana essential oil on mice through monoaminergic modulation using the forced swimming test
Abbasi-Maleki, S., Kadkhoda, Z., & Farid, R. T. (2019) · Journal of Traditional and Complementary Medicine · doi:10.1016/j.jtcme.2019.01.003 · Cited by 79
Reverse cholesterol transport and lipid peroxidation biomarkers in major depression and bipolar disorder: A systematic review and meta-analysis
Almulla, A. F., Thipakorn, Y., Algon, A. A. A., Tunvirachaisakul, C., Al‐Hakeim, H. K., & Maes, M. H. J. (2023) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2023.08.007 · Cited by 79
Fluoxetine affects antioxidant system and promotes apoptotic signaling in Wistar rat liver
Djordjevic, J., Djordjevic, A., Adzic, M., Elaković, I., Matić, G., & Radojcic, M. B. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.03.003 · Cited by 78
Highly potent radical scavenging-anti-oxidant activity of biologically reduced graphene oxide using Nettle extract as a green bio-genic amines-based reductants source instead of hazardous hydrazine hydrate
Mahmudzadeh, M., Yari, H., Ramezanzadeh, B., & Mahdavian, M. (2019) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2019.03.046 · Cited by 78
Targeting Inflammatory-Mitochondrial Response in Major Depression: Current Evidence and Further Challenges
Visentin, A. P. V., Colombo, R., Scotton, E., Fracasso, D. S., Rosa, A. R., Branco, C. S., & Salvador, M. M. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/2972968 · Cited by 77
Total antioxidant capacity of diet and serum, dietary antioxidant vitamins intake, and serum hs-CRP levels in relation to depression scales in university male students
Prohan, M., Amani, R., Nematpour, S., Jomehzadeh, N., & Haghighizadeh, M. H. (2014) · Redox Report · doi:10.1179/1351000214y.0000000085 · Cited by 77
Generalized Anxiety Disorder (GAD) and Comorbid Major Depression with GAD Are Characterized by Enhanced Nitro-oxidative Stress, Increased Lipid Peroxidation, and Lowered Lipid-Associated Antioxidant Defenses
Maes, M. H. J., Bonifácio, K. L., Morelli, N. R., Vargas, H. O., Moreira, E. G., Stoyanov, D., Barbosa, D. S., Carvalho, A. F., & Nunes, S. O. V. (2018) · Neurotoxicity Research · doi:10.1007/s12640-018-9906-2 · Cited by 78
Lower whole blood glutathione peroxidase (GPX) activity in depression, but not in myalgic encephalomyelitis / chronic fatigue syndrome: another pathway that may be associated with coronary artery disease and neuroprogression in depression.
Maes, M. H. J., Mihaylova, I., Kubera, M., Uytterhoeven, M., Vrydags, N., & Bosmans, E. (2011) · PubMed · Cited by 76
Oxidative Imbalance and Anxiety Disorders
Krolow, R., Arcego, D. M., Noschang, C. G., Weis, S. N., & Dalmaz, C. (2014) · Current Neuropharmacology · doi:10.2174/1570159x11666131120223530 · Cited by 76
Gastrodiae Rhizoma (天麻 tiān má): a review of biological activity and antidepressant mechanisms
Chen, P., & Sheen, L. (2011) · Journal of Traditional and Complementary Medicine · doi:10.1016/s2225-4110(16)30054-2 · Cited by 75
Antidepressant-like effects of ascorbic acid and ketamine involve modulation of GABAA and GABAB receptors
da Rosa, P. B., Neis, V. B., Ribeiro, C. M., Moretti, M., & Rodrigues, A. L. S. (2016) · Pharmacological Reports · doi:10.1016/j.pharep.2016.05.010 · Cited by 76
An intricate relationship between pain and depression: clinical correlates, coactivation factors and therapeutic targets
Chopra, K., & Arora, V. K. (2013) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2014.855720 · Cited by 77
Oxidative stress and glutathione response in tissue cultures from persons with major depression
Gibson, S. A., Korade, Ž., & Shelton, R. C. (2012) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2012.06.008 · Cited by 71
Is there Progress? An Overview of Selecting Biomarker Candidates for Major Depressive Disorder
Young, J. J., Silber, T., Bruno, D., Galatzer‐Levy, I. R., Pomara, N., & Marmar, C. R. (2016) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2016.00072 · Cited by 73
Oxidation-reduction mechanisms in psychiatric disorders: A novel target for pharmacological intervention
Rossetti, A. C., Paladini, M. S., Riva, M. A., & Molteni, R. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107520 · Cited by 73
A preclinical and clinical rationale for quetiapine in mood syndromes
McIntyre, R. S., Soczynska, J. K., Woldeyohannes, H. O., Alsuwaidan, M. T., & Konarski, J. Z. (2007) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.8.9.1211 · Cited by 70
A meta-analysis of lipid peroxidation markers in major depression
Lanctôt, K. L., Mazereeuw, G., Herrmann, N., Andreazza, A. C., & Khan, M. M. (2015) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s89922 · Cited by 69
Importance of oxidative stress in the pathogenesis, diagnosis, and monitoring of patients with neuropsychiatric disorders, a review
Cecerska-Heryć, E., Polikowska, A., Serwin, N., Roszak, M., Grygorcewicz, B., Heryć, R., Michalczyk, A., & Dołęgowska, B. (2022) · Neurochemistry International · doi:10.1016/j.neuint.2021.105269 · Cited by 68
α-Tocopherol administration produces an antidepressant-like effect in predictive animal models of depression
Lobato, K. R., Cardoso, C. C., Binfaré, R. W., Budni, J., Wagner, C. L. R., Brocardo, P. S., de Souza, L. F., Brocardo, C., Flesch, S., Freitas, A. E., et al. (2010) · Behavioural Brain Research · doi:10.1016/j.bbr.2010.02.002 · Cited by 67
DNA Damage in Major Psychiatric Diseases
Raza, M. U., Tufan, T., Wang, Y., Hill, C. P., & Zhu, M. (2016) · Neurotoxicity Research · doi:10.1007/s12640-016-9621-9 · Cited by 70
The molecular aspects of oxidative & nitrosative stress and the tryptophan catabolites pathway (TRYCATs) as potential causes of depression
Wigner, P., Czarny, P. L., Gałecki, P., Su, K., & Śliwiński, T. (2017) · Psychiatry Research · doi:10.1016/j.psychres.2017.09.045 · Cited by 65
The Association of Major Depressive Disorder with Activation of NLRP3 Inflammasome, Lipid Peroxidation, and Total Antioxidant Capacity
Tane, A., Khalili‐Tanha, G., Esmaeili, A., Mobasheri, L., Kooshkaki, O., Jafari, S., Shokouhifar, A., & Sarab, G. A. (2019) · Journal of Molecular Neuroscience · doi:10.1007/s12031-019-01401-0 · Cited by 63
Oxidant/antioxidant status in premenstrual syndrome
Duvan, C. İ., Cumaoğlu, A., Turhan, N. Ö., Karasu, Ç., & Kafalı, H. C. (2010) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-009-1347-y · Cited by 63
Hydrogen Sulfide Protects against Chronic Unpredictable Mild Stress‐Induced Oxidative Stress in Hippocampus by Upregulation of BDNF‐TrkB Pathway
Hu, M., Zou, W., Wang, C., Chen, X., Tan, H., Zeng, H.-Y., Zhang, P., Gu, H., & Tang, X. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/2153745 · Cited by 63
Oxidative Stress Markers and Antioxidant Enzymes in Children and Adolescents with Depressive Disorder and Impact of Omega-3 Fatty Acids in Randomised Clinical Trial
Katrenčíková, B., Vaváková, M., Paduchová, Z., Nagyová, Z., Garaiová, I., Muchová, J., Ďuračková, Z., & Trebatická, J. (2021) · Antioxidants · doi:10.3390/antiox10081256 · Cited by 63
Depression and anxiety symptoms are associated with prooxidant-antioxidant balance: A population-based study
Shafiee, M., Ahmadnezhad, M., Tayefi, M., Arekhi, S., Vatanparast, H., Esmaily, H., Moohebati, M., Ferns, G. A., Mokhber, N., Arefhosseini, S. R., et al. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.05.079 · Cited by 62
Effects of peony glycosides on mice exposed to chronic unpredictable stress: Further evidence for antidepressant-like activity
Mao, Q., Ip, S., Ko, K., Tsai, S.-H., Xian, Y., & Che, C. (2009) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2009.04.019 · Cited by 62
Inflammatory markers in coronary artery disease
Ikonomidis, I., Michalakeas, C. A., Parissis, J., PARASKEVAIDIS, I. A., Ntaï, K., Papadakis, I., ANASTASIOU‐NANA, M. I., & Lekakis, J. P. (2012) · BioFactors · doi:10.1002/biof.1024 · Cited by 64
Clinical correlation of alteration of endogenous antioxidant-uric acid level in major depressive disorder
Chaudhari, K., Khanzode, S. D., Khanzode, S. D., Dakhale, G. N., Saoji, A., & Sarode, S. C. (2010) · Indian Journal of Clinical Biochemistry · doi:10.1007/s12291-010-0016-z · Cited by 60
Self-citation
Fruit and vegetable intake in relation to depressive and anxiety symptoms among adolescents in 25 low- and middle-income countries.
Liu, M.-W., Chen, Q., Towne, S. D. C., Zhang, J., Yu, H.-J., Tang, R., Gasevic, D., Wang, P.-G., & He, Q.-Q. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2019.10.007 · Cited by 50
Guanosine prevents behavioral alterations in the forced swimming test and hippocampal oxidative damage induced by acute restraint stress
Bettio, L. E. B., Freitas, A. E., Neis, V. B., Santos, D. B., Ribeiro, C. M., da Rosa, P. B., Farina, M., & Rodrigues, A. L. S. (2014) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2014.10.002 · Cited by 59
Protective effects of peony glycosides against corticosterone-induced cell death in PC12 cells through antioxidant action
Mao, Q., Xian, Y., Ip, S., Tsai, S.-H., & Che, C. (2010) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2010.11.043 · Cited by 59
Vitamin C as an adjuvant for treating major depressive disorder and suicidal behavior, a randomized placebo-controlled clinical trial
Sahraian, A., Ghanizadeh, A. J., & Kazemeini, F. (2015) · Trials · doi:10.1186/s13063-015-0609-1 · Cited by 59
Protocol and rationale-the efficacy of minocycline as an adjunctive treatment for major depressive disorder: a double blind, randomised, placebo controlled trial
Dean, O. M., Maes, M., Ashton, M., Berk, L., Kanchanatawan, B., Sughondhabirom, A., Tangwongchai, S., Ng, C., Dowling, N., Malhi, G. S., et al. (2014) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2014.12.3.180 · Cited by 58
In major affective disorders, early life trauma predict increased nitro-oxidative stress, lipid peroxidation and protein oxidation and recurrence of major affective disorders, suicidal behaviors and a lowered quality of life
Moraes, J. B., Maes, M. H. J., Roomruangwong, C., Bonifácio, K. L., Barbosa, D. S., Vargas, H. O., Anderson, G., Kubera, M., Carvalho, A. F., & Nunes, S. O. V. (2018) · Metabolic Brain Disease · doi:10.1007/s11011-018-0209-3 · Cited by 60
Oxidative stress parameters and antioxidants in adults with unipolar or bipolar depression versus healthy controls: Systematic review and meta-analysis
Jiménez‐Fernández, S., Gurpegui, M., Rojas, D. G., Gutiérrez-Rojas, L., Carretero, M. D., & Correll, C. U. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.07.015 · Cited by 60
Etazolate, a phosphodiesterase 4 inhibitor reverses chronic unpredictable mild stress-induced depression-like behavior and brain oxidative damage
Jindal, A., Mahesh, R., & Bhatt, S. (2013) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2013.01.020 · Cited by 59
Involvement of glutathione, ERK1/2 phosphorylation and BDNF expression in the antidepressant-like effect of zinc in rats
Franco, J. L. (2007) · Behavioural Brain Research · doi:10.1016/j.bbr.2007.11.012 · Cited by 57
Possible mechanism of the antidepressant effect of 3,6′-disinapoyl sucrose from Polygala tenuifolia Willd
Hu, Y., Liu, M., Liu, P., Guo, D., Wei, R., & Rahman, K. (2011) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.2011.01281.x · Cited by 56
Nitric Oxide Mimetic Molecules as Therapeutic Agents in Alzheimers Disease
Thatcher, G. R. J., Bennett, B. M., & Reynolds, J. N. (2005) · Current Alzheimer Research · doi:10.2174/1567205053585945 · Cited by 56
NLRP3 Inflammasome: From Pathophysiology to Therapeutic Target in Major Depressive Disorder
Kouba, B. R., Gil‐Mohapel, J., & Rodrigues, A. L. S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010133 · Cited by 57
Chronic selective serotonin reuptake inhibition modulates endothelial dysfunction and oxidative state in rat chronic mild stress model of depression
Matchkov, V. V., Васильевна, К. В., Wiborg, O., Aalkjær, C., & Bouzinova, E. V. (2015) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00337.2014 · Cited by 55
Association study between plasma GDNF and cognitive function in late-onset depression
Wang, X., Hou, Z., Yuan, Y., Hou, G., Liu, Y., Li, H., & Zhang, Z. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.03.043 · Cited by 55
Ascorbic Acid to Manage Psychiatric Disorders
Moretti, M., Fraga, D. B., & Rodrigues, A. L. S. (2017) · CNS Drugs · doi:10.1007/s40263-017-0446-8 · Cited by 57
Evidence for protective effect of lipoic acid and desvenlafaxine on oxidative stress in a model depression in mice
Silva, M. C. C., de Sousa, C. N. S., Gomes, P. X. L., de Oliveira, G. V., de Araújo, F. Y. R., Ximenes, N. C., da Silva, J. C., Vasconcelos, G. S., Leal, L. K. A. M., Macêdo, D. S., et al. (2015) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2015.08.002 · Cited by 52
The Effect of Chronic Mild Stress and Imipramine on the Markers of Oxidative Stress and Antioxidant System in Rat Liver
Duda, W., Curzytek, K., Kubera, M., Iciek, M., Kowalczyk‐Pachel, D., Bilska‐Wilkosz, A., Lorenc‐Koci, E., Leśkiewicz, M., Basta‐Kaim, A., Budziszewska, B., et al. (2016) · Neurotoxicity Research · doi:10.1007/s12640-016-9614-8 · Cited by 52
Depression in middle and older adulthood: the role of immigration, nutrition, and other determinants of health in the Canadian longitudinal study on aging
Davison, K., Lung, Y., Lin, S., Tong, H., Kobayashi, K. M., & Fuller‐Thomson, E. (2019) · BMC Psychiatry · doi:10.1186/s12888-019-2309-y · Cited by 55
The impact of depression and anxiety treatment on biological aging and metabolic stress: study protocol of the Mood treatment with antidepressants or running (MOTAR) study
Milligen, B. A. L.-V., Verhoeven, J. E., Schmaal, L., van Velzen, L. S., Révész, D., Black, C. N., Han, L. K. M., Horsfall, M., Batelaan, N. M., van Balkom, A. J. L. M., et al. (2019) · BMC Psychiatry · doi:10.1186/s12888-019-2404-0 · Cited by 52
Restorative Biological Processes and Health
Robles, T. F., & Carroll, J. (2011) · Social and Personality Psychology Compass · doi:10.1111/j.1751-9004.2011.00368.x · Cited by 51
Histone acetylation and expression of mono-aminergic transmitters synthetases involved in CUS-induced depressive rats
Liu, D., Qiu, H.-M., Fei, H.-Z., Hu, X.-Y., Xia, H.-J., Wang, L.-J., Qin, L.-J., Jiang, X.-H., & Zhou, Q.-X. (2014) · Experimental Biology and Medicine · doi:10.1177/1535370213513987 · Cited by 49
Role of Oxidative Stress and Ca2+ Signaling in Psychiatric Disorders
Nakao, A., Matsunaga, Y., Hayashida, K., & Takahashi, N. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.615569 · Cited by 51
A tomato-rich diet is related to depressive symptoms among an elderly population aged 70 years and over: A population-based, cross-sectional analysis
Niu, K., Guo, H., Kakizaki, M., Cui, Y., Ohmori‐Matsuda, K., Guan, L., Hozawa, A., Kuriyama, S., Tsuboya, T., Ohrui, T., et al. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.04.040 · Cited by 49
Anti-depressant-like effect of peony: a mini-review
Mao, Q., Ip, S., Xian, Y., Hu, Z. J., & Che, C. (2011) · Pharmaceutical Biology · doi:10.3109/13880209.2011.602696 · Cited by 50
Evaluation of antidepressant-like effects of aqueous and ethanolic extracts of Pimpinella anisum fruit in mice.
Shahamat, Z., Abbasi-Maleki, S., & Motamed, S. M. (2016) · Europe PMC (PubMed Central) · Cited by 48
Variation of genes involved in oxidative and nitrosative stresses in depression
Wigner, P., Czarny, P. L., Synowiec, E., Bijak, M., Białek, K. I., Talarowska, M. E., Gałecki, P., Szemraj, J., & Śliwiński, T. (2018) · European Psychiatry · doi:10.1016/j.eurpsy.2017.10.012 · Cited by 48
Chronic variable stress impairs energy metabolism in prefrontal cortex and hippocampus of rats: prevention by chronic antioxidant treatment
Tagliari, B., Noschang, C. G., Ferreira, A. G. K., Ferrari, O. A., Feksa, L. R., Wannmacher, C. M. D., Dalmaz, C., & Wyse, Â. T. D. S. (2010) · Metabolic Brain Disease · doi:10.1007/s11011-010-9194-x · Cited by 50
Microglia under psychosocial stressors along the aging trajectory: Consequences on neuronal circuits, behavior, and brain diseases
Tian, L., Hui, C. W., Bisht, K., Tan, Y., Sharma, K. P., Chen, S., Zhang, X., & Tremblay, M. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.01.007 · Cited by 52
Effects of selective serotonin reuptake inhibitors on DNA damage in patients with depression
Ahmadimanesh, M., Abbaszadegan, M. R., Rad, D. M., Moallem, S. A., Mohammadpour, A. H., Ghahremani, M. H., Hosseini, F. F., Behdani, F., Manteghi, A. A., Jowsey, P. A., et al. (2019) · Journal of Psychopharmacology · doi:10.1177/0269881119874461 · Cited by 47
Transdermal Selegiline:The New Generation of Monoamine Oxidase Inhibitors
Patkar, A. A., Pae, C., & Masand, P. S. (2006) · CNS Spectrums · doi:10.1017/s1092852900014498 · Cited by 46
Dietary total antioxidant capacity in relation to depression and anxiety in Iranian adults
Milajerdi, A., Keshteli, A. H., Afshar, H., Esmaillzadeh, A., & Adibi, P. (2018) · Nutrition · doi:10.1016/j.nut.2018.11.017 · Cited by 47
Early Life Trauma Predicts Affective Phenomenology and the Effects are Partly Mediated by Staging Coupled with Lowered Lipid-Associated Antioxidant Defences
Maes, M. H. J., Congio, A. C., Moraes, J. B., Bonifácio, K. L., Barbosa, D. S., Vargas, H. O., Morris, G., Puri, B. K., Michelin, A. P., & Nunes, S. O. V. (2018) · BioMolecular Concepts · doi:10.1515/bmc-2018-0010 · Cited by 47
Molecular correlates of mitochondrial dysfunctions in major depression: Evidence from clinical and rodent studies
Rappeneau, V., Wilmes, L., & Touma, C. (2020) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2020.103555 · Cited by 47
5HT3 receptors: Target for new antidepressant drugs
Gupta, D., Prabhakar, V., & Radhakrishnan, M. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.03.001 · Cited by 47
The antioxidant gallic acid induces anxiolytic-, but not antidepressant-like effect, in streptozotocin-induced diabetes
Pereira, M. M., Morais, H., Silva, E. D. S., Corso, C. R., Adami, E. R., Carlos, R. M., Acco, A., & Zanoveli, J. M. (2018) · Metabolic Brain Disease · doi:10.1007/s11011-018-0264-9 · Cited by 45
Alterations in leukocyte transcriptional control pathway activity associated with major depressive disorder and antidepressant treatment
Mellon, S. H., Wolkowitz, O. M., Schonemann, M. D., Epel, E. S., Rosser, R., Burke, H. B., Mahan, L., Reus, V. I., Stamatiou, D., Liew, C. C., et al. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.79 · Cited by 46
Oxidative stress, anti-oxidants and the cross-sectional and longitudinal association with depressive symptoms: results from the CARDIA study
Black, C. N., Penninx, B. W. J. H., Bot, M., Odegaard, A., Gross, M., Matthews, K. A., & Jacobs, D. R. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.5 · Cited by 44
Chronic variable stress induces oxidative stress and decreases butyrylcholinesterase activity in blood of rats
Tagliari, B., dos Santos, T. M., da Cunha, A. A., de Lima, D. D., Delwing, D., Sitta, Â., Vargas, C. R., Dalmaz, C., & Wyse, Â. T. D. S. (2010) · Journal of Neural Transmission · doi:10.1007/s00702-010-0445-0 · Cited by 43
Advancements Exploring Major Depressive Disorder: Insights on Oxidative Stress, Serotonin Metabolism, BDNF, HPA Axis Dysfunction, and Pharmacotherapy Advances
Correia, A. S., & Vale, N. (2024) · International Journal of Translational Medicine · doi:10.3390/ijtm4010010 · Cited by 43
Association of dietary total antioxidant capacity to anthropometry in healthy women: A cross-sectional study
Mozaffari, H., Daneshzad, E., Larijani, B. A., Surkan, P. J., & Azadbakht, L. (2019) · Nutrition · doi:10.1016/j.nut.2019.110577 · Cited by 41
Clinical Evidence of Antidepressant Effects of Insulin and Anti-Hyperglycemic Agents and Implications for the Pathophysiology of Depression—A Literature Review
Woo, Y. S., Lim, H. K., Wang, S., & Bahk, W. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186969 · Cited by 43
Construction of a nitro-oxidative stress-driven, mechanistic model of mood disorders: A nomothetic network approach
Simeonova, D., Stoyanov, D., Leunis, J., Murdjeva, M., & Maes, M. H. J. (2020) · Nitric Oxide · doi:10.1016/j.niox.2020.11.001 · Cited by 41
Regulation of embryonic neurotransmitter and tyrosine hydroxylase protein levels by ascorbic acid
Meredith, M. E., & May, J. M. (2013) · Brain Research · doi:10.1016/j.brainres.2013.09.040 · Cited by 41
Cardiometabolic disease and features of depression and bipolar disorder: Population-based, cross-sectional study
Martin, D. J., Haq, Z. U., Nicholl, B. I., Cullen, B., Evans, J. J., Gill, J. M. R., Roberts, B. A., Gallacher, J., Mackay, D., McIntosh, A. M., et al. (2016) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.114.157784 · Cited by 42
Effects of antidepressants on mRNA levels of antioxidant enzymes in human monocytic U-937 cells
Schmidt, A. J., Heiser, P., Hemmeter, U. M., Krieg, J.-C., & Vedder, H. (2008) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2008.05.024 · Cited by 40
The Role of Water-Soluble Vitamins and Vitamin D in Prevention and Treatment of Depression and Seasonal Affective Disorder in Adults
Jahan-Mihan, A., Stevens, P., Medero-Alfonso, S., Brace, G., Overby, L. K., Berg, K., & Labyak, C. A. (2024) · Nutrients · doi:10.3390/nu16121902 · Cited by 40
Decreased expression of heme oxygenase is associated with depressive symptoms and may contribute to depressive and hypertensive comorbidity
Robaczewska, J., Kędziora–Kornatowska, K., Kucharski, R., Nowak, M., Muszalik, M., Kornatowski, M., & Kędziora, J. (2016) · Redox Report · doi:10.1080/13510002.2015.1101889 · Cited by 40
Medical and substance-related comorbidity in bipolar disorder: translational research and treatment opportunities
Mclntyre, R. S., Nguyen, H. T., Soczynska, J. K., Lourenço, M. T. C., Woldeyohannes, H. O., & Konarski, J. Z. (2008) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2008.10.2/rsmcintyre · Cited by 41
Lipids in health and disease
Finkelstein, J. M., Heemels, M.-T., Shadan, S., & Weiss, U. K. (2014) · Nature · doi:10.1038/510047a · Cited by 41

Authors: Khanzode, S. D., Dakhale, G. N., Khanzode, S. S., Saoji, A., & Palasodkar, R.
Affiliations: Government Medical College (IN)
ORCID: Dakhale, Ganesh N.
Venue: Redox Report
Publisher: Informa UK Limited
Published: 2003-12
Volume: 8
Issue: 6
Pages: 365-370
ISSN: 1351-0002 (ISSN-L)
1743-2928
DOI: 10.1179/135100003225003393
OpenAlex: W2090999800
Cited by: 458
References: 27
Citations by year: 2026: 11 · 2025: 17 · 2024: 24 · 2023: 14 · 2022: 27 · 2021: 19 · 2020: 24 · 2019: 25 · 2018: 29 · 2017: 23 · 2016: 25 · 2015: 29 · 2014: 35 · 2013: 29 · 2012: 30
FWCI: 3.00
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Redox Report (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
Health Sciences › Medicine › Biochemistry (medical) › Antioxidant Activity and Oxidative Stress
Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
Keywords: major depressive disorder, oxidative stress, selective serotonin reuptake inhibitors, fluoxetine, citalopram, lipid peroxidation, malondialdehyde, superoxide dismutase, vitamin C, antioxidant defense, antidepressant response prediction
MeSH terms: Adult, Antioxidants, Ascorbic Acid, Depression, Female, Fluoxetine, Humans, Male, Malondialdehyde, Middle Aged, Prospective Studies, Superoxide Dismutase, Time Factors, Lipid Peroxidation, Citalopram, Selective Serotonin Reuptake Inhibitors, Oxidative Stress

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Oxidative damage and major depression: the potential antioxidant action of selective serotonin re-uptake inhibitors

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks